On Wednesday shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) closed at $23.20. Company’s EPS growth for next 5 years is recorded as 15.00%. Citigroup Inc. downgraded shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) from a buy rating to a neutral rating in a report issued on Thursday.
On last trading day Telecom Italia S.p.A. (NYSE:TI) decreased -1.00% to close at $11.88. Its volatility for the week is 1.80% while volatility for the month is 1.71%. TI’s sales growth for past 5 years was -4.40% and its EPS growth for past 5 years was -19.70%. Telecom Italia S.p.A. (NYSE:TI) monthly performance is 2.86%. Telecom Italia S.p.A. (NYSE:TI) has announced the public launch of its crowd funding platform, dubbed WithYouWeDo, with a stated aim to support ideas and projects in the fields of digital culture, social innovation and environmental protection.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) has 0.10% insider ownership while its institutional ownership stands at 15.80%. In last trading activity company’s stock closed at $1.41. On 31 March, Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) announced the peer-reviewed publication of clinical data from a Phase I investigator-sponsored trial evaluating the company’s lead investigational immunotherapy bavituximab plus paclitaxel therapy in patients with HER2-negative metastatic breast cancer. The manuscript details the results of the Phase I trial showing that the combination produced an objective tumor response in 85% of patients, including 15% of these patients achieving a complete response, measured in accordance with Response Evaluation Criteria In Solid Tumors (RECIST) criteria.
On last trading day ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) moved up 4.05% to close at $34.17. Its volatility for the week is 4.40% while volatility for the month is 6.14%. ACAD’s sales growth for past 5 years was -56.50% and its EPS growth for past 5 years was 4.60%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) monthly performance is -12.23%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced that it will present at the 14th Annual Needham Healthcare Conference on Tuesday April 14 2015 at 9:20 a.m. Eastern Time in New York City.